Probing the physicochemical and structural requirements for glycogen synthase kinase-3alpha inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2006-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMC.2006.09.021PMID 17010615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Analysis of the Ortho Effect

  2007cited by this paper
• 3D QSAR for GSK-3beta inhibition by indirubin analogues.

  2006cited by this paper
• 3D QSAR for GSK-3β inhibition by indirubin analogues

  2006cited by this paper
• Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses.

  2006cited by this paper
• QSAR modeling of the inhibition of glycogen synthase kinase-3.

  2006cited by this paper
• New leads for selective GSK-3 inhibition: pharmacophore mapping and virtual screening studies

  2006cited by this paper
• Inhibition of GSK-3β as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition

  2005cited by this paper
• 3D QSAR studies on GSK-3 inhibition by aloisines.

  2005cited by this paper
• 3D-QSAR and Docking Studies of Selective GSK-3beta Inhibitors. Comparison with a Thieno[2, 3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3beta Ligands

  2005cited by this paper
• SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.

  2005cited by this paper
• Valency and Bonding: A Natural Bond Orbital Donor-Acceptor Perspective

  2005cited by this paper
• Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

  2004cited by this paper
• Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors.

  2004cited by this paper
• Glycogen synthase kinase 3: a drug target for CNS therapies

  2004cited by this paper
• GSK-3 inhibitors: discoveries and developments.

  2004cited by this paper
• Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.

  2004cited by this paper
• Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418*

  2003cited by this paper
• Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

  2003cited by this paper
• GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

  2003cited by this paper
• 6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

  2003cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003cited by this paper
• Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.

  2003cited by this paper
• 5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

  2003cited by this paper
• Comparative QSAR of the sulfonamide function.

  2003cited by this paper
• 6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

  2003cited by this paper
• Cyclooxygenase (COX) inhibitors: a comparative QSAR study.

  2003cited by this paper
• 5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

  2003cited by this paper
• Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β

  2002cited by this paper
• GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease

  2002cited by this paper
• Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.

  2002cited by this paper
• Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.

  2002cited by this paper
• An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling

  2002cited by this paper
• Bond orders in heteroaromatic rings

  2002cited by this paper
• Role of glycogen synthase kinase-3 in skeletal muscle insulin resistance in Type 2 diabetes.

  2002cited by this paper
• Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.

  2002cited by this paper
• Structure of GSK3β reveals a primed phosphorylation mechanism

  2001cited by this paper
• On Interpretation of Well-Known Topological Indices

  2001cited by this paper
• Structure of GSK3beta reveals a primed phosphorylation mechanism.

  2001cited by this paper
• Glycogen synthase kinase-3: properties, functions, and regulation.

  2001cited by this paper
• Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

  2001cited by this paper
• Crystal Structure of Glycogen Synthase Kinase 3β: Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition

  2001cited by this paper
• 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

  2001cited by this paper
• Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

  2000cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.

  1999cited by this paper
• The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

  1995cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• Molecular cloning and expression of glycogen synthase kinase‐3/factor A.

  1990cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper
• Glycogen synthase kinase-3 from rabbit skeletal muscle.

  1981cited by this paper
• Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.

  1980cited by this paper
• Substituent constants for correlation analysis in chemistry and biology

  1979cited by this paper
• Structure-activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters.

  1971cited by this paper
• p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure

  1964cited by this paper

• Design, Microwave Synthesis, Antibacterial Activity, ADMET, and Photo Physical Analysis of 3‐Styryl‐2H‐Chromene‐Fused Maleimide Derivatives as Potential DNA Gyrase Inhibitors

  2025cites this paper
• Catalyst-free aroylation of maleimides through Csp2-H functionalization with aldehydes and benzyl phenyl sulfides.

  2025cites this paper
• Synthesis of 3,4-Disubstituted Maleimide Derivatives via Phosphine-Catalyzed Isomerization of α-Succinimide-Substituted Allenoates Cascade γ′-Addition with Aryl Imines

  2024cites this paper
• Organocatalyzed asymmetric Mannich reaction of α-aminomaleimides with N-Boc imines

  2024cites this paper
• Advances in organocatalyzed synthesis of organic compounds

  2024cites this paper
• Synthesis, characterization and anti-breast cancer activity of some maleimide derivatives

  2023cites this paper
• Developing a straightforward route toward the synthesis of arylaminomaleimides by palladium-catalyzed arylation of one-pot synthesized aminomaleimides.

  2023cites this paper
• Novel maleic anhydride derivatives: liquid crystalline materials with enhanced mesomorphic and optical characteristics

  2023cites this paper
• Design, Synthesis and Building a QSAR model for the inhibition of Mycobacterium tuberculosis by Pyrazoline derivatives

  2022cites this paper
• Combined Computational and Experimental Studies on the Asymmetric Michael Addition of α-Aminomaleimides to β-Nitrostyrenes Using an Organocatalyst Derived from Cinchona Alkaloid.

  2021cites this paper
• Novel Schiff bases derived from N-aryl maleimide derivatives as an effective antimicrobial agent: Theoretical and experimental approach.

  2020cites this paper
• DOCKING STUDIES ON IMIDAZOLIDINE ANALOGUES FOR MANAGEMENT OF DIABETES

  2017cites this paper
• Biochemistry & Pharmacology: Open Access

  2017cites this paper
• Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors.

  2017cites this paper
• Synthesis and Characterization of Novel Semicarbazone Derivatives of Disubstituted N-arylmaleimides

  2016cites this paper
• Simple, rapid, and clean condensation of sulfonamide and maleic anhydride derivatives: Synthesis of novel 1H- Pyrrole-2,5-diones under heterogeneous conditions

  2016cites this paper
• Scaffold and cell line based approaches for QSAR studies on anticancer agents

  2015cites this paper
• Eco-friendly synthesis and 2D-QSAR study of novel pyrazolines as potential anticolon cancer agents

  2015cites this paper
• Monte Carlo method based QSAR modeling of maleimide derivatives as glycogen synthase kinase-3β inhibitors

  2015cites this paper
• State of Art: Review of Theoretical Study of GSK-3β and a New Neural Networks QSAR Studies for the Design of New Inhibitors Using 2D-Descriptors

  2015cites this paper
• Possible links between Diabetes Mellitus and Alzheimer’s disease

  2014cites this paper
• PLS and shape-based similarity analysis of maleimides – GSK-3 inhibitors

  2014cites this paper
• Current view from Alzheimer disease to type 2 diabetes mellitus.

  2014cites this paper
• Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies.

  2014cites this paper
• Synthesis and biological evaluation of novel N-aryl maleimide derivatives clubbed with α-hydroxyphosphonates.

  2014cites this paper
• Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

  2014cites this paper
• Substituted naphthalen-1-yl-acetic acid hydrazides: synthesis, antimicrobial evaluation and QSAR analysis.

  2013cites this paper
• Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors.

  2013cites this paper
• Solvent-mediated One-pot Synthesis of Cyclic N-Substituted Imides

  2013cites this paper
• Original Open Access

  2013cites this paper
• Discovery of Novel Glycogen Synthase Kinase-3beta Inhibitors: Molecular Modeling, Virtual Screening, and Biological Evaluation

  2012cites this paper
• Synthesis, antimycobacterial, antiviral, antimicrobial activity and QSAR studies of N(2)-acyl isonicotinic acid hydrazide derivatives.

  2012cites this paper
• Hansch analysis 50 years on

  2012cites this paper
• In silico classification and virtual screening of maleimide derivatives using projection to latent structures discriminant analysis (PLS-DA) and hybrid docking

  2012cites this paper
• Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design.

  2012cites this paper
• Review of theoretical studies for prediction of neurodegenerative inhibitors.

  2012cites this paper
• (Naphthalen-1-yloxy)-acetic acid benzylidene/(1-phenyl-ethylidene)-hydrazide derivatives: synthesis, antimicrobial evaluation, and QSAR studies

  2012cites this paper
• Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies

  2012cites this paper
• Construcción QSAR de redes complejas de compuestos de interés en Química Farmacéutica, Microbiología y Parasitología

  2011cites this paper
• Computational medicinal chemistry in fragment-based drug discovery: what, how and when.

  2011cites this paper
• Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

  2011cites this paper
• Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models

  2011cites this paper
• Adaptive variable-weighted support vector machine as optimized by particle swarm optimization algorithm with application of QSAR studies.

  2011cites this paper
• A New Protocol for Predicting Novel GSK-3β ATP Competitive Inhibitors

  2011cites this paper
• Topological polar surface area: a useful descriptor in 2D-QSAR.

  2009cites this paper
• Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking

  2009cites this paper
• Commonality Between Diabetes and Alzheimer’s Disease and A New Strategy for the Therapy

  2008cites this paper
• Common pathological processes in Alzheimer disease and type 2 diabetes: a review.

  2007cites this paper
• MED-SuMoLig: A New Ligand-Based Screening Tool for Efficient Scaffold Hopping

  2007cites this paper
• QSAR studies for the pharmacological inhibition of glycogen synthase kinase-3.

  2007cites this paper
• Is Glucagon-like peptide-1, an agent treating diabetes, a new hope for Alzheimer’s disease?

  2007cites this paper